SEC Form 4 · accession 0001354488-15-000522
Midatech Pharma US Inc. · DARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher G Clement
Officer — Chief Executive Officer · Director
Period of report
Feb 9, 2015
Accepted (ET)
Feb 9, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000919745
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.79 | Feb 9, 2015 | A | 264,000 | A | — | Feb 9, 2025 | Common Stock | 264,000 | 264,000 | D |
Explanation of responses
- F1This option was granted on February 9, 2015 and vests in five equal installments with the first installment vesting upon grant and the remaining installments vesting annually thereafter.